Vetted by NeuralPress's Multi-Agent Verifier for strict factual validity and event relevance. Our compliance engine cross-checks and filters search results to ensure zero false correlations or misleading content.
Primary Sources
Israel's Benjamin Netanyahu says he was treated for prostate cancer
JERUSALEM — Israeli Prime Minister Benjamin Netanyahu said Friday that he has undergone treatment for prostate cancer in his first public acknowledgment of the diagnosis. What You Need To Know Israeli Prime Minister Benjamin Netanyahu says that he has undergone treatment for prostate cancer It was his first public acknowledgment of the diagnosis He said that roughly a year and a half ago he had prostate surgery Then two and a half months ago, his doctors discovered and treated a small tumor at Jerusalem's Hadassah Hospital with radiation therapy He said that roughly a year and a half ago he had prostate surgery. Then two and a half months ago, his doctors discovered and treated a small tumor at Jerusalem's Hadassah Hospital with radiation therapy. That was not announced at the time. "I requested to delay its publication by two months so that it would not be released at the height of the war" against Iran, the 76-year-old Israeli leader said, to prevent "more false propaganda against Israel." He said he was healthy and called the tumor a "minor medical issue." Netanyahu's health was the subject of speculation during the early weeks of the war with Iran as fake, AI-generated images circulated suggesting he had died, including on Iranian state media. Aharon Popovtser, the director of Hadassah Hospital's oncology unit, said Netanyahu was diagnosed at an early stage, noting that prostate cancer is common among men his age. "We can say based on the findings of these tests that the disease has disappeared," he said, referring to imaging and blood work. Israel's longest-serving prime minister — who is overseeing not just the war in Iran but also conflicts in Gaza and Lebanon — has faced criticism in the past for not disclosing information about his health, including when he told the public he had a pacemaker implanted to address a long-standing heart condition a week after he fainted at a public appearance.
Israel's Netanyahu says he was treated for prostate cancer
April 24, 2026, 11:17 a.m. ETTEL AVIV – Israeli Prime Minister Benjamin Netanyahu said on Friday, April 24, that he had received successful treatment for early-stage prostate cancer, without specifying when the treatment took place.In a statement on social media, as his annual medical report was released, Netanyahu, 76, said an early stage malignant tumor had been discovered during a routine checkup. He said "targeted treatment" had removed "the problem" and left no trace of it.According to the medical report, which otherwise said the prime minister was in good health, Netanyahu was treated with radiation therapy for early-stage prostate cancer. Neither the medical report nor Netanyahu said when the treatment occurred.Israel's longest-serving prime minister said that he had delayed the release of the medical report by two months to prevent Iran from spreading "false propaganda against Israel."In March, during the fighting with Iran, rumors that circulated on social media and aired on Iranian state media claimed that Netanyahu had died. The Israeli leader recorded a video of himself visiting a Jerusalem cafe in March to refute the claims.Netanyahu underwent surgery on his prostate in 2024 after he was diagnosed with a urinary tract infection resulting from a benign prostate enlargement. In 2023, he was fitted with a pacemaker. Elections are due to be held in Israel by October.
Israeli Prime Minister Benjamin Netanyahu treated for prostate cancer
Israeli Prime Minister Benjamin Netanyahu says he has received treatment for prostate cancer. The 76-year-old said the early stage malignant tumour was discovered during a check-up. What's next?
Benjamin Netanyahu treated for early-stage prostate cancer
The 76 year-old Israeli leader said he underwent the initial surgery for an enlarged benign prostate in 2024 and has been under routine medical monitoring.
